This bill has not been voted on.
Contribution data provided by the Center for Responsive Politics (OpenSecrets.org)
Comments 
HR 1218 by Navid Khajehnajafi, Jun 29, 2008 (10:36pm)
The predecessor Pharmaceutical Market Access Act of 2003 managed to pass the house on a roll call vote, with the Congressional Budget Office forecasting a $40 billion consumer savings in prescription drug expenditures over 10 years if the act made law. All other versions of the bill failed to make it to a vote.

Latest Comments
See More | New Comment